Clinical Applications and Prevention

Behavioral, environmental, clinical, and healthcare approaches to reduce the occurrence and consequences of cardiovascular diseases. Studies include clinical and community trials and selected observational studies.

Program Officers

Rebecca Campo, Ph.D.
Social determinants of health, psychosocial risk
301-594-1047
Lawrence Fine, MD, Dr.PH, FAHA
Senior Advisor; Hypertension; prevention
301-435-0305
Charlotte Pratt, Ph.D., M.S., R.D, FAHA
Deputy Branch Chief; Nutrition; CVH across the Lifespan
301-435-0382
Nicole Redmond, M.D., Ph.D., M.P.H.
Branch Chief; Health equity; career development
301-435-0379
Joni Snyder, R.N., BSN, M.A.
Clinical trials; hypertension; vascular dementia
301-435-0408
Laurie Friedman Donze, Ph.D.
Obesity; physical activity; psychiatric comorbidities of CVD; adherence
301-827-1408